Plain-English Summary
TinyHumanMD is a decision-support website, not a healthcare provider. Nothing here is medical advice, diagnosis, or treatment direction. You must independently verify every output before using it in any real-world workflow. If you use this site, you accept that responsibility for decisions, compliance, and outcomes remains with you and your organization.
These Terms also limit liability, disclaim warranties, require lawful use, and include indemnity protections for the site owner and contributors to the maximum extent permitted by law.
1. Acceptance of Terms
By accessing or using TinyHumanMD, you agree to these Terms of Use and Medical Disclaimer. If you do not agree, do not use the site. Continued use after posted updates means you accept the updated Terms.
2. Intended Users
This site is intended for trained adult users, including clinicians, trainees under supervision, and healthcare-adjacent professionals who can evaluate outputs responsibly. If you are not qualified to interpret outputs, you must not rely on them for care or policy decisions.
3. Decision-Support-Only Status
TinyHumanMD is informational software for decision support. It is not a healthcare provider, emergency system, telemedicine service, EHR/EMR, pharmacy order system, or medical device authorization authority.
4. No Medical Advice
Nothing on this site constitutes medical advice, diagnosis, treatment, prescription guidance, or individualized clinical recommendation. Outputs are computational aids that must be interpreted by qualified humans.
5. No Professional Relationship
Use of TinyHumanMD does not create a clinician-patient relationship, fiduciary relationship, agency relationship, consultancy engagement, or duty of care owed by the site owner or contributors.
6. Independent Verification Duty
You must independently verify outputs before implementation. Verification includes checking data quality, units, timing assumptions, contraindications, and compatibility with current authoritative guidance and local policy.
Verification is ongoing. You must re-check when context changes, standards update, or uncertainty appears.
7. Emergency and High-Risk Exclusion
Do not use TinyHumanMD as the sole basis for emergency or high-risk decisions. In urgent situations, follow emergency protocols and direct supervision first.
8. User Input Responsibility
You are solely responsible for all values entered and interpreted, including unit conversions, dates, medication concentrations, and assumptions. Outcomes caused by incorrect, incomplete, stale, or unauthorized inputs are your responsibility.
9. Institutional Policy Controls
Institutional policy and applicable law always take priority over website outputs. If there is any conflict, do not implement until qualified reviewers resolve it under your local governance process.
10. Compliance Responsibility
You and your institution are solely responsible for compliance with applicable laws, regulations, licensing obligations, accreditation standards, payer rules, privacy duties, and internal governance requirements.
11. Assumption of Risk
You assume all risk arising from use, misuse, non-use, interpretation, implementation, delay, non-implementation, and reliance or non-reliance on site outputs.
12. Warranty Disclaimer
To the maximum extent permitted by law, TinyHumanMD is provided "as is" and "as available" without warranties of any kind, express or implied, including merchantability, fitness for a particular purpose, accuracy, completeness, uninterrupted availability, and non-infringement.
13. Limitation of Liability
To the maximum extent permitted by law, the site owner, maintainers, and contributors are not liable for direct, indirect, incidental, consequential, special, punitive, exemplary, reputational, regulatory, clinical, or economic losses arising from use of this site.
14. Liability Cap and Exclusive Remedy
If liability is imposed despite these limitations, aggregate liability is capped at the greater of USD $100 or the amount you directly paid for access in the prior 12 months (which may be $0). Your exclusive remedy is to stop using the site.
15. Indemnification
You agree to defend, indemnify, and hold harmless the site owner and contributors from claims, penalties, losses, liabilities, and reasonable legal fees arising from your use, misuse, policy violations, unauthorized processing, or legal noncompliance.
16. Acceptable Use
You may not use this site for unlawful activity, harassment, fraud, security abuse, deceptive representation, or unauthorized automation that degrades service integrity.
17. Intellectual Property
Unless otherwise stated, site content and branding are protected by applicable intellectual property laws. Access is granted only for lawful use under these Terms.
18. Third-Party References
The site may link to third-party resources. Those are governed by their own terms and privacy notices. TinyHumanMD does not control and does not warrant third-party content or services.
19. Service Changes and Availability
Features, formulas, and content may be changed, suspended, or removed at any time without notice. No obligation exists to preserve backward compatibility.
20. Security Limits
No internet system guarantees perfect security or uptime. You accept residual risk from infrastructure failures, software defects, endpoint compromise, and human error.
21. Privacy Policy Integration
Use of the site is also governed by the Privacy Policy. These Terms and the Privacy Policy should be read together and interpreted consistently.
22. US and UK/EU Legal Overlay
Where mandatory local law provides non-waivable rights, those rights apply. Otherwise, these Terms apply to the fullest extent permitted by law. This document is not legal advice.
23. Governing Law and Venue
These Terms are governed by the law chosen by the site owner, excluding conflict-of-law rules where permitted. Venue is in forums selected by the site owner unless mandatory law requires otherwise.
24. Class Waiver and Claim Deadline
To the maximum extent permitted by law, claims must be brought individually and not as class or representative actions. Claims must be filed within one year of accrual unless non-waivable law requires a longer period.
25. Severability and Survival
If any clause is unenforceable, remaining clauses stay in force. Disclaimers, liability limits, indemnity obligations, and dispute provisions survive termination.
26. Entire Agreement and Updates
These Terms and the Privacy Policy are the complete agreement for site use. Informal statements do not modify this agreement. Revisions become effective when posted.
27. Final Responsibility Statement
TinyHumanMD is an informational decision-support tool. Final responsibility for legal compliance, clinical judgment, implementation, and outcomes remains with users and their institutions.
Implementation Guidance Annex (Non-Contractual)
The following implementation guidance is practical and non-contractual. Organizations should establish written controls for tool approval, user competency, escalation thresholds, and post-implementation audit review.
Recommended safeguards include source verification checklists, dual review for high-risk contexts, contraindication review checkpoints, and sign-off records where policy requires supervisory authorization.
Governance teams should distinguish educational use from production use, define prohibited use cases, and require exception logging when tool output conflicts with local policy.
Where multidisciplinary teams are involved, assign clear ownership for data entry, output review, and final decision authority. Ambiguity in ownership creates preventable risk.
For high-volume settings, institutions should implement periodic quality sampling to detect unit mismatches, assumption drift, or improper reliance patterns before adverse events occur.
For cross-border operations, maintain jurisdiction-specific compliance overlays and require legal review before introducing outputs into regulated pathways.
Extended Operational Risk Annex
R-1. Clinical Review Thresholds
Organizations should define which decisions may rely on single-review workflows and which require dual-review or specialist sign-off. Thresholds should be written and enforced.
For R-1, implementation ownership remains with the user organization. These Terms do not create replacement duties for local governance, and they should be interpreted to preserve independent verification, supervision, and legal compliance obligations before any operational action is taken.
R-2. Formulary and Dosing Governance
Where medication outputs are considered, local formulary constraints and concentration policies must govern final decisions. Website outputs cannot override local medication governance.
For R-2, implementation ownership remains with the user organization. These Terms do not create replacement duties for local governance, and they should be interpreted to preserve independent verification, supervision, and legal compliance obligations before any operational action is taken.
R-3. Handoff Integrity Standards
Transitions between clinicians or teams should include verified context, unresolved-question flags, and documented reviewer identity to prevent reliance on incomplete assumptions.
For R-3, implementation ownership remains with the user organization. These Terms do not create replacement duties for local governance, and they should be interpreted to preserve independent verification, supervision, and legal compliance obligations before any operational action is taken.
R-4. Supervisory Accountability
In trainee-involved workflows, supervisors should retain explicit accountability for final authorization when policy requires oversight.
For R-4, implementation ownership remains with the user organization. These Terms do not create replacement duties for local governance, and they should be interpreted to preserve independent verification, supervision, and legal compliance obligations before any operational action is taken.
R-5. Exception Handling Discipline
When local policy and output interpretation diverge, teams should use exception workflows with documented rationale rather than informal workaround behavior.
For R-5, implementation ownership remains with the user organization. These Terms do not create replacement duties for local governance, and they should be interpreted to preserve independent verification, supervision, and legal compliance obligations before any operational action is taken.
R-6. Quality-Audit Sampling
Routine retrospective sampling should detect patterns such as shortcutting verification, repeated unit mismatches, or policy bypass under time pressure.
For R-6, implementation ownership remains with the user organization. These Terms do not create replacement duties for local governance, and they should be interpreted to preserve independent verification, supervision, and legal compliance obligations before any operational action is taken.
R-7. Operational Stress Conditions
Policies should address degraded operation scenarios, including staffing constraints, interruptions, and overnight coverage, where reliance risk may increase.
For R-7, implementation ownership remains with the user organization. These Terms do not create replacement duties for local governance, and they should be interpreted to preserve independent verification, supervision, and legal compliance obligations before any operational action is taken.
R-8. Dispute Preservation Practices
If disputes arise, institutions should preserve relevant records, review notes, and policy references needed to reconstruct decision pathways accurately.
For R-8, implementation ownership remains with the user organization. These Terms do not create replacement duties for local governance, and they should be interpreted to preserve independent verification, supervision, and legal compliance obligations before any operational action is taken.
R-9. Communications Accuracy
Users should avoid representing TinyHumanMD outputs as authoritative orders in messaging or chart notes without proper contextual qualification and validation documentation.
For R-9, implementation ownership remains with the user organization. These Terms do not create replacement duties for local governance, and they should be interpreted to preserve independent verification, supervision, and legal compliance obligations before any operational action is taken.
R-10. Procurement and Contract Alignment
If institutional policy requires contractual warranties or service levels, those requirements must be satisfied through separate procurement channels and cannot be implied from public website access.
For R-10, implementation ownership remains with the user organization. These Terms do not create replacement duties for local governance, and they should be interpreted to preserve independent verification, supervision, and legal compliance obligations before any operational action is taken.